Factors Associated with Remaining on Initial Randomized Efavirenz-containing Regimens in the AIDS Clinical Trials Group

OBJECTIVE: Efavirenz (EFV) plus 2 nucleoside reverse transcriptase inhibitors (NRTIs) is a recommended initial antiretroviral (ARV) regimen. Understanding characteristics related to EFV success is clinically useful. DESIGN: Data from 2,220 ARV-naïve participants randomized to EFV + 2/3 NRTIs in 4 AC...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Smurzynski, Marlene, Wu, Kunling, Schouten, Jeffrey T., Lok, Judith J., Bosch, Ronald J., Taiwo, Babafemi, Johnson, Victoria Anne, Collier, Ann C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4204654/
https://ncbi.nlm.nih.gov/pubmed/23925417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e328361645f
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak